#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Subclinical acute rejections in protocol biopsies at 3 months after kidney transplantation


Authors: I. Matl 1;  E. Honsová 2;  A. Lodererová 2;  V. Lánská 3;  O. Viklický 1
Authors‘ workplace: Klinika nefrologie IKEM Praha, přednosta doc. MUDr. Ondřej Viklický, CSc. 1;  Pracoviště klinické a transplantační patologie IKEM Praha, přednostka prim. MUDr. Eva Honsová, Ph. D. 2;  Oddělení lékařské statistiky IKEM Praha 3
Published in: Vnitř Lék 2008; 54(11): 1054-1058
Category: Original Contributions

Overview

Aim:
The primary aim of the study was detection of subclinical acute rejection and borderline changes in protocol biopsies at 3 months after transplantation, and assessment of possible clinical and laboratory associations.

Methods:
Biopsy was carried out in 194 patients with stabilized graft function. Patients were treated with immunosuppressive regimen based on cyclosporine A (n = 34), tacrolimus (n = 152), or sirolimus/everolimus (n = 10). Samples were processed by standard paraffine technique, and stained according to laboratory protocol. All samples were tested by immunofluorescence or immunohistochemical procedures for C4d presence as a sign of humoral rejection.

Results:
Of 192 representative samples, subclinical acute rejection and borderline changes were found in 24 samples (12.5%). In patients with this finding, the mean serum creatinine was significantly higher (185.2 ± 2.2 µmol/L), than in patients with normal finding (128.2 ± 28.3 µmol/L) p < 0.001. Using the ROC curve analysis of serum creatinine, the cut‑off point 170 µmol/L was found to discriminate normal findings from subclinical rejection and borderline changes. A significant correlation between acute rejections before protocol biopsy and subclinical acute rejections together with borderline changes in protocol biopsy was found. C4d positivity was found in 6 samples. Immunosuppressive therapy (cyclosporine versus tacrolimus) did not have any impact on subclinical acute rejections and borderline changes prevalence.

Conclusions:
The main conclusion of this study is a finding, that acute rejection early after renal transplantation and serum creatinine ≥ 170 µmol/l at three months after transplantation are risks for development of subclinical acute rejection, even of humoral type, or borderline changes.

Key words:
kidney transplantation – protocol biopsy – subclinical acute rejection – borderline changes – immunosuppressive therapy


Sources

1. Burdick JF, Beschorner WE, Smith WJ et al. Characteristics of early routine renal allograft biopsies. Transplantation 1984; 38: 679–684.

2. Choi BS, Shin MJ, Shin SJ et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005; 5: 1354–1360.

3. Furness PN, Philpott CM, Chorbadjian MT et al. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 2003; 76: 969–973.

4. Gloor JM, Cohen AJ, Lager DJ et al. Subclinical rejection in tacrolimus‑treated renal transplant recipients. Transplantation 2002; 73: 1965–1968.

5. Helanterä I, Ortiz F, Helin H et al. Timing and value of protocol biopsies in well‑matched kidney transplant recipients – a clinical and histopathologic analysis. Transplant Int 2007; 20: 982–990.

6. Horčička V Jr, Krejčí K, Zadražil J et al. Arteriovenózní píštěl jako komplikace bio-psie ledvin. Vnitř Lék 2002; 48: 432–437.

7. Kanetsuna Y, Yamaguchi Y, Toma H et al. Histological evaluation of renal allograft protocol biopsies in the early period and 1 year after transplantation. Clin Transplant 2003; 17 (Suppl 10): 25–29.

8. Kee TYS, Chapman JR, Connell PJ et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82: 36–42.

9. Koo DD, Roberts IS, Quiroga I et al. C4d deposition in early allograft protocol biopsies. Transplantation 2004; 78: 398–403.

10. Legendre C, Thervet E, Skhiri H et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998; 65: 1506–1509.

11. Matl I, Viklický O, Voska L et al. Naše první zkušenosti s protokolární bio-psií transplantovaných ledvin. Čas Lék Čes 2004; 143: 253–256.

12. Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Amer J Transplantation 2007; 7: 356–365.

13. Moreso F, Alperovich G, Fulladosa X et al. Histologic findings in protocol biopsies performed in stable renal allografts under different immunosuppressive schedules. Transplant Proc 2003; 35: 1666–1668.

14. Nankivell BJ, Fenton-Lee CA, Kuypers DRJ et al. Effect of histological damage on long‑term kidney transplant outcome. Transplantation 2001; 71: 515–523.

15. Nankivell BJ, Borrows RJ, Fung CLS et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242–249.

16. Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Amer J Transplantation 2006; 6: 2006–2012.

17. Ponticelli C, Banfi G. The case against protocol kidney biopsies. Transplant Proc 2002; 34: 1716–1718.

18. Racusen LC, Colvin RB, Solez K. An-tibody-mediated rejection criteria – an addition to the Banff ’97 classification of renal allograft rejection. Amer J Transplantation 2003; 3: 708–714.

19. Racusen LC, Solez K, Colvin B et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713–723.

20. Rush D, Jeffery JT, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59: 511–514.

21. Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early sub-clinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129–2134.

22. Scholten EM, Rowshani AT, Cremers S et al. Untreated rejection in 6-month protocol biopsy is not associated with fibrosis or with loss of graft function. J Am Soc Nephrol 2006; 17: 2622–2632.

23. Schück O, Smrčková I, Teplan V et al. Nová metoda stanovení glomerulární filtrace na podkladě sérové koncentrace kreatininu, močoviny a albuminu (MDRD). Vnitř Lék 2004; 50: 507–509.

24. Serón D, Moreso F, Ramón JM et al. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 2000; 69: 1849–1855.

25. Sund S, Hovig T, Reisaeter A et al. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003; 75: 1204–1213.

26. Tichý T, Tichý M, Zadražil J et al. Histologické nálezy v protokolárních biopsiích transplantovaných ledvin. Čes Slov Patol 2003; 39: 11–16.

27. Veronese FV, Noronha IL, Manfro RC et al. Protocol biopsies in renal transplant patients: three years’ follow‑up. Transplant Proc 2002; 34: 500–501.

Labels
Diabetology Endocrinology Internal medicine

Article was published in

Internal Medicine

Issue 11

2008 Issue 11

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#